H.R. 4019

119 HR 4019 IH: Gio’s Law
 U.S. House of Representatives
 2025-06-17
 text/xml
 EN
 Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
 I  119th CONGRESS  1st Session  H. R. 4019  IN THE HOUSE OF REPRESENTATIVES   June 17, 2025   Ms. Gillen  (for herself and  Mr. Garbarino ) introduced the following bill; which was referred to the  Committee on the Judiciary    A BILL
To amend the Omnibus Crime Control and Safe Streets Act of 1968 to establish a grant program for provide access to, and training on the administration of, epinephrine products for law enforcement officers, and for other purposes.
1.
Short title
This Act may be cited as   Gio’s Law  .
2.
Law Enforcement Access to Emergency Epinephrine Grant Program
Title I of the Omnibus Crime Control and Safe Streets Act of 1968 ( 34 U.S.C. 10101 et seq. ) is amended by adding at the end the following:
PP
Law Enforcement Access to Emergency Epinephrine Grant Program
3061.
Grant authorization
The Attorney General is authorized to make grants under this part to States and units of local government to—
(1)
purchase epinephrine products for use by State, local, and tribal law enforcement agencies;
(2)
train State, local, and tribal law enforcement officers, in accordance with the curricula developed or identified under section 3062.
3062.
Standardized training
Not later than 180 days after the date of enactment of this part, the Attorney General shall develop a training curricula, or identify effective existing training curricula, to train law enforcement officer to—
(1)
recognize the symptoms of an anaphylactic reaction; and
(2)
correctly administer epinephrine products to any individual reasonably believed to be having an anaphylactic reaction.
3063.
Application
The chief executive of a State or unit of local government seeking a grant under this part shall submit to the Attorney General an application at such time, in such manner, and containing such information as the Attorney General may reasonably require, including a certification of the State attorney general of the State, or the State in which the unit of local government is located, that a law enforcement officer who is authorized in that jurisdiction to administer epinephrine products to any individual reasonably believed to be having an anaphylactic reaction is protected from civil liability arising from administering such a product.
3064.
Definition
In this part, the term  epinephrine product  means—
(1)
an epinephrine auto-injector; and
(2)
a product that facilitates the administration of epinephrine other than by injection.
3065.
Authorization of appropriations
There is authorized to be appropriated $25,000,000 to carry out this part for each of fiscal years 2026 through 2030.
  .
3.
Report on administration of epinephrine by law enforcement officers
On an annual basis, the Attorney General, acting through the Director of the Bureau of Justice Statistics, shall submit to Congress and make publicly available, data on the frequency of the administration of epinephrine products (as such term is defined in section 3064 of title I of the Omnibus Crime Control and Safe Streets Act of 1968) by Federal, State, local, and tribal law enforcement officers.
4.
Interagency Public Awareness and Outreach Campaign
 Not later than 180 days after the date of enactment of this Act, the Attorney General, in collaboration with the Secretary of Health and Human Services, shall design and implement a public awareness campaign to educate members of the public about—
(1)
the symptoms of an anaphylactic reaction; and
(2)
the role of law enforcement officers and first responders in administering epinephrine products.